Neurovalens Expands Access to Modius Sleep for Veterans Through U.S. Department of Veterans Affairs (VA) Program

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

BELFAST, Northern Ireland, Feb. 24, 2025 /PRNewswire/ — Neurovalens, a global leader in noninvasive neurostimulation technology, is making significant strides in addressing chronic insomnia among U.S. veterans. The company’s FDA-cleared, drug-free insomnia treatment device, Modius Sleep, is now available to veterans through the U.S. Department of Veterans Affairs (VA) program.

Insomnia is a significant concern among veterans, with studies showing that nearly 40% of U.S. veterans experience clinical or subthreshold insomnia, a rate far higher than that of the general population (source). Beyond disrupted sleep, insomnia is linked to increased stress, cognitive impairment, and a higher risk of chronic health conditions, making effective solutions critical for veteran well-being. Source: https://jcsm.aasm.org/doi/10.5664/jcsm.9182

Developed by Neurovalens, Modius Sleep is an FDA-cleared, award-winning, drug-free device designed to treat chronic insomnia. Using advanced noninvasive neurostimulation, the device targets key brain regions responsible for sleep regulation, helping users fall asleep faster, stay asleep longer, and improve overall sleep quality.

Jason McKeown, MD, CEO of Neurovalens, commented:
“We are honored to make Modius Sleep available to veterans through the VA program. Sleep issues are a significant challenge for many veterans, and we are proud to offer an effective, drug-free solution that can have a meaningful impact on their health and well-being. This partnership with the VA is a testament to our commitment to improving lives through technology.”

Veterans struggling with chronic insomnia can request Modius Sleep through their local VA healthcare provider or contact Neurovalens directly to explore how this FDA-cleared, drug-free solution can help improve their sleep and overall well-being.

About Modius Sleep
Neurovalens is a global health-tech company specializing in noninvasive neurostimulation solutions designed to address some of the world’s most pressing health challenges. The company’s FDA-cleared Modius technology targets the brain regions responsible for sleep and circadian rhythm regulation, using low-level electrical stimulation of the vestibular nerve to support better sleep, stress management, and overall well-being. Headquartered in Belfast, United Kingdom, Neurovalens is committed to advancing drug-free, neuroscience-driven therapies to improve health outcomes worldwide.

For more information, visit www.neurovalens.com/modiussleep

Contact: Kate Willis
kate.willis@neurovalens.com
+1 513-532-2378

View original content to download multimedia:https://www.prnewswire.com/news-releases/neurovalens-expands-access-to-modius-sleep-for-veterans-through-us-department-of-veterans-affairs-va-program-302382856.html

SOURCE Neurovalens

Staff

Recent Posts

Patientory’s AI-Enterprise Analytics Dashboard Now Available on Oracle Healthcare Marketplace

Patientory's Enterprise Analytics Dashboard is now integrated with Oracle Health technologies to support proactive care,…

47 minutes ago

CENTEGIX ® Accelerates Nationwide Safety Momentum in 2025, Protecting over 15,000 Sites and over 15 Million People

Demand for innovative safety solutions across schools, healthcare facilities, and government organizations drives growth ATLANTA,…

47 minutes ago

Brook.ai Honored as a Company of the Year in 2025 Silver Stevie Awards for Technology Excellence

SEATTLE, Aug. 19, 2025 /PRNewswire/ -- Brook.ai, a leader in remote care, empowering providers and patients…

47 minutes ago

Convoke Raises $8.6M to Build the AI Operating System for Biopharma

Convoke's platform turns raw data into deliverables, helping drug developers accelerate the path from idea…

47 minutes ago

Premera Blue Cross Launches Premera Health Hub to Expand Digital Health, Enhance Member Experience

New digital health network available January 1, 2026, for self-funded employers in Washington and Alaska…

47 minutes ago

Dismas Charities Expands Use of Atlas Digital Behavioral Health Platform to 40 Sites Nationwide

After a successful pilot, Dismas Charities partners with The Change Companies to bring individualized, digital-first…

47 minutes ago